These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3995171)

  • 1. The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activation.
    McNeely TB; Griffith MJ
    Blood; 1985 May; 65(5):1226-31. PubMed ID: 3995171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo correlation of clotting protease activity: effect of heparin.
    Gitel SN; Stephenson RC; Wessler S
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3028-32. PubMed ID: 268650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
    Minami H; Nogami K; Yada K; Ogiwara K; Furukawa S; Soeda T; Kitazawa T; Shima M
    J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.
    Griffith MJ; Breitkreutz L; Trapp H; Briet E; Noyes CM; Lundblad RL; Roberts HR
    J Clin Invest; 1985 Jan; 75(1):4-10. PubMed ID: 3871202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
    Pieters J; Willems G; Hemker HC; Lindhout T
    J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
    Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
    J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic processing of human coagulation factor IX by plasmin.
    Samis JA; Ramsey GD; Walker JB; Nesheim ME; Giles AR
    Blood; 2000 Feb; 95(3):943-51. PubMed ID: 10648407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
    Blaskó G
    Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor Xa inactivation by a heparinized hydrogel.
    Rollason G; Sefton MV
    Thromb Res; 1986 Nov; 44(4):517-25. PubMed ID: 3798412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A candidate activation pathway for coagulation factor VII.
    Misenheimer TM; Kumfer KT; Bates BE; Nettesheim ER; Schwartz BS
    Biochem J; 2019 Oct; 476(19):2909-2926. PubMed ID: 31537632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of acetaldehyde-glycosaminoglycan mixtures upon Factor IXa and Factor IX-Deficient Plasma.
    Brecher AS; Moon AR; Gray KD
    Alcohol; 2006 Jun; 39(2):97-104. PubMed ID: 17134662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of blood coagulation at heparin-coated surfaces.
    Blezer R; Fouache B; Willems GM; Lindhout T
    J Biomed Mater Res; 1997 Oct; 37(1):108-13. PubMed ID: 9335355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
    Vinazzer H; Woler M
    Thromb Res; 1985 Oct; 40(2):135-46. PubMed ID: 3878009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.